News
The U.K.-based drug maker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.
Loe said that while Fast Track status doesn’t guarantee PMN310 will succeed in future Phase II or III Alzheimer’s trials, it ...
With Richard Ayoade with David Letterman, Robert Downey Jr., Kamilah Forbes, Scott Galloway, Tom Hanks, Becky Kennedy, and ...
A lawsuit filed in federal court on behalf of the University of Pennsylvania and its health system alleges that 20 years of skyrocketing prices on drugs that treat diabetes, like insulin, can be ...
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The money will focus on a manufacturing plant in Virginia that will make the company's weight management and metabolic drugs ...
Ms. Korczynski joined Aquestive in February 2024 to lead the Company's sales and marketing initiatives. With more than two decades of commercial and launch experience across leadership roles at ANI ...
Eli Lilly, Summit Therapeutics, and Vertex Pharmaceuticals all have important ongoing clinical trials. Shares of these ...
The best stocks to invest in often are industry leaders in vast markets. These five stocks are likely to continue making ...
Eli Lilly faces a pivotal moment as its stock experiences a slight pullback. Investors are eyeing its upcoming earnings ...
AstraZeneca said the "cornerstone" of the commitment would be a new weight management production facility for its oral GLP-1 ...
AstraZeneca PLC plans to invest $50 billion in the US before 2030, becoming the latest European pharma company to ratchet up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results